MAPT and Alzheimer disease: Moreover, the plasma Aβ42/Aβ40 ratio showed a significant correlation with the process of degeneration measured in CSF (t-Tau, ratio t-Tau/Aβ42), as well as with the specific AD diagnosis (CSF Aβ42).